11 December 2018 | News | By NFS Correspondent
Peak Health, a leading nutrition, health and wellness company in the US dedicated to improving human health, has signed an agreement with CloudNine Co., Ltd., a Japanese wellness company, to provide its product ImmunAG.
Under the agreement, Peak Health will provide CloudNine with ImmunAG in medium chain triglyceride (MCT) Oil for distribution and sales as its cannabis derived cannabidiol (CBD) products. ImmunAG is the first-ever non-cannabis derived CBD product. Alternatively, the product is made from Kriya brand Humulus, a cousin to hops which makes it legal in all countries.
Peak Health has developed a line of phytoceutical (bioactive plant-based) remedies and has a patent-pending on ImmunAG, a major addition to the product line and the first-ever non-cannabis derived cannabidiol (CBD) product.